长链非编码RNA CASC2抑制肿瘤发生发展的研究概况

doi:10.11904/j.issn.1002-3070.2018.02.018

摘要/Abstract

摘要： 长链非编码RNA(lncRNA)包括大部分人类DNA的非编码信息,占整个基因组的90%以上。lncRNA由超过200个核苷酸组成,通常缺乏开放阅读框并参与肿瘤的病理生理过程。lncRNA能调控各种肿瘤基因表达、印记、转录和翻译后修饰等。2004年在子宫内膜癌(EC)中首次发现lncRNA癌易感性候选基因2(Cancer susceptibility candidate 2,CASC2)可能是潜在的抑癌基因。而后发现CASC2在诸如宫颈癌、大肠癌、胃癌、肝癌、非小细胞肺癌、肾细胞癌、膀胱癌、神经胶质瘤和甲状腺癌等中都表达下调,而CASC2过表达时能抑制肿瘤细胞增殖,这说明CASC2有抑癌作用。在肾上腺癌等其他肿瘤中CASC2的转录水平不变,表明CASC2的抑癌作用具有组织特异性。本文对CASC2在肿瘤中的抑癌作用及相关机制做一综述。

关键词: 长链非编码RNA, lncRNA, CASC2, 肿瘤

Abstract: Long non-coding RNA(lncRNA)includes the non-coding information of most human DNA,accounting for more than 90% of the entire genome.LncRNAs consist of more than 200 nucleotides,usually lacking open reading frames and participating in the pathophysiology of the tumor.LncRNA can regulate a variety of tumor gene expression,imprinting,transcription and post-translational processing.LncRNA cancer susceptibility candidate 2(CASC2)as a potential tumor suppressor gene was first discovered in the endometrial carcinoma(EC)in 2004.CASC2 was found to be downregulated in tumors such as cervical cancer,colorectal cancer,gastric cancer,liver cancer,non-small cell lung cancer,renal cell carcinoma,bladder cancer,glioma and thyroid cancer,while CASC2 overexpression inhibited tumor cell proliferation.This shows that CASC2 has tumor suppressor effect.In other tumors such as adrenal adenocarcinoma,the transcriptional level of CASC2 remained unchanged,indicating that the tumor suppressor effect of CASC2 is tissue-specific.This review summarizes the research progress of CASC2 in tumor origin,progression,mechanisms,and clinical therapeutic effects.

Key words: Long non-coding RNA, lncRNA, CASC2, Cancer

中图分类号:

杨钊, 赵世光. 长链非编码RNA CASC2抑制肿瘤发生发展的研究概况[J]. 实用肿瘤学杂志, 2018, 32(2): 179-183.

YANG Zhao, ZHAO Shiguang. Long non-coding RNA CASC2 inhibits progression and development of tumor[J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(2): 179-183.

参考文献

1 Huang G,Wu X,Li S,et al.The long noncoding RNA CASC2 functions as a competing endogenous RNA by sponging miR-18a in colorectal cancer[J].Scientific Reports,2016,6:26524.
2 Fatima R,Akhade VS,Pal D,et al.Long noncoding RNAs in development and cancer:potential biomarkers and therapeutic targets[J].Mol Cell Ther,2015,3(1):5.
3 Yu X,Li Z.Long non-coding RNA growth arrest-specific transcript 5 in tumor biology[J].Oncology Letters,2015,10(4):1953.
4 Yu X,Li Z.Long non-coding RNA HOTAIR:A novel oncogene(Review)[J].Molecular Medicine Reports,2015,12(4):5611.
5 Sun J,Ding C,Yang Z,et al.The long non-coding RNA TUG1 indicates a poor prognosis for colorectal cancer and promotes metastasis by affecting epithelial-mesenchymal transition[J].J Transl Med,2016,14(1):42.
6 Lennox KA,Behlke MA.Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides[J].Nucleic Acids Research,2016,44(2):863-877.
7 Mu Z,Liu J,Jia X,et al.Lnc-mg is a long non-coding RNA that promotes myogenesis[J].Nature Communications,2017,8:14718.
8 Fan Z,Zhao M,Joshi PD,et al.A class of circadian long non-coding RNAs mark enhancers modulating long-range circadian gene regulation[J].Nucleic Acids Research,2017,45(10):5720-5738.
9 Jiang R,Tang J,Chen Y,et al.The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion[J].Nature Communications,2017,8:15129.
10 Baldinu P,Cossu A,Manca A,et al.Identification of a novel candidate gene,CASC2,in a region of common allelic loss at chromosome 10q26 in human endometrial cancer[J].Hum Mutat,2004,23(4):318-326.
11 Feng Y,Zou W,Hu C,et al.Modulation of CASC2/miR-21/PTEN pathway sensitizes cervical cancer to cisplatin[J].Arch Biochem Biophys,2017,623:20-30.
12 Baldinu P,Cossu A,Manca A,et al.CASC2a gene is down-regulated in endometrial cancer[J].Anticancer Research,2007,27(1A):235.
13 Peng L,Xue WJ,Ying F,et al.Long non-coding RNA CASC2 suppresses the proliferation of gastric cancer cells by regulating the MAPK signaling pathway[J].Am J Transl Res,1943,8(8):3522-3529.
14 Zhou J,Huang H,Tong S,et al.Overexpression of long non-coding RNA cancer susceptibility 2 inhibits cell invasion and angiogenesis in gastric cancer[J].Molecular Medicine Reports,2017,16(4):5235-5240.
15 Gan Y,Han N,He X,et al.Long non-coding RNA CASC2 regulates cell biological behaviour through the MAPK signalling pathway in hepatocellular carcinoma[J].Tumour Biol,2017,39(6):1010428317706229.
16 Wang Y,Liu Z,Yao B,et al.Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis[J].Molecular Cancer,2017,16(1):123.
17 Yu Y,Liang S,Zhou Y,et al.HNF1A/CASC2 regulates pancreatic cancer cell proliferation through PTEN/Akt signaling[J].J Cell Biochem,2017[Epub ahead of print].
18 He X,Liu Z,Su J,et al.Low expression of long noncoding RNA CASC2 indicates a poor prognosis and regulates cell proliferation in non-small cell lung cancer[J].Tumour Biol,2016,37(7):9503-9510.
19 Cao Y,Xu R,Xu X,et al.Downregulation of lncRNA CASC2 by microRNA-21 increases the proliferation and migration of renal cell carcinoma cells[J].Molecular Medicine Reports,2016,14(1):1019-1025.
20 Pei Z,Xian D,Song Y,et al.Down-regulation of lncRNA CASC2 promotes cell proliferation and metastasis of bladder cancer by activation of the Wnt/β-catenin signaling pathway[J].Oncotarget,2017,8(11):18145.
21 Wang P,Liu YH,Yao YL,et al.Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21[J].Cell Signal,2015,27(2):275-282.
22 Liao Y,Shen L,Zhao H,et al.LncRNA CASC2 interacts with miR-181a to modulate glioma growth and resistance to TMZ through PTEN pathway[J].J Cell Biochem,2017,118(7):1889-1899.
23 Wang R,Li Y,Zhu G,et al.Long noncoding RNA CASC2 predicts the prognosis of glioma patients and functions as a suppressor for gliomas by suppressing Wnt/β-catenin signaling pathway[J].Neuropsy chiatr Dis Treat,2017,13:1805-1813.
24 Xiong X,Zhu H,Chen X.Low expression of long noncoding RNA CASC2 indicates a poor prognosis and promotes tumorigenesis in thyroid carcinoma[J].Biomed Pharmacother,2017,93:391-397.
25 Steinbakk A,Malpica A,Slewa A,et al.High frequency microsatellite instability has a prognostic value in endometrial endometrioid adenocarcinoma,but only in FIGO stage 1 cases[J].Cellular Oncology,2011,34(5):457-465.
26 Xin W,Liu X,Ding J,et al.Long non-coding RNA derived miR-205-5p modulates human endometrial cancer by targeting PTEN[J].Am J Transl Res,2015,7(11):2433-2441.

[1]	孙力超,杨婧,孙立新,张媛,杨治华,冉宇靓. 采用肝癌球体细胞筛选鉴定识别肝癌干细胞的单抗[J]. 实用肿瘤学杂志, 2019, 33(3): 193-199.
[2]	张佳文,于雁,张薇,曹京燕,罗雯,尚利华. 基于UPLC-TOF/MS的小细胞肺癌患者血清代谢组学研究[J]. 实用肿瘤学杂志, 2019, 33(3): 200-205.
[3]	张茂祥,孙惠昕,宋冰冰. 2008—2012年哈尔滨市道里区恶性肿瘤发病与死亡分析[J]. 实用肿瘤学杂志, 2019, 33(3): 261-265.
[4]	刘乙澍,曲国蕃. 长链非编码RNA在骨肉瘤中的研究进展[J]. 实用肿瘤学杂志, 2019, 33(3): 266-270.
[5]	侯玉雪,李晓莉. Wnt7a与恶性肿瘤的关系及研究进展[J]. 实用肿瘤学杂志, 2019, 33(3): 271-275.
[6]	朱琳,张春霞. 纳米载药系统靶向肿瘤干细胞的研究进展[J]. 实用肿瘤学杂志, 2019, 33(3): 276-279.
[7]	徐晖, 李希, 周春水. 应用以人转录组为靶点的shRNA文库筛选肺癌肿瘤相关抑制基因[J]. 实用肿瘤学杂志, 2019, 33(2): 97-102.
[8]	李诚, 兰莉, 杨超, 张婷婷, 王蕊, 林琳, 田文静. 2015—2017年哈尔滨市恶性肿瘤发病与死亡特征分析[J]. 实用肿瘤学杂志, 2019, 33(1): 62-66.
[9]	丁界先, 张津, 陈永刚, 王兴文综述, 王栓科审校. Wnt信号通路与肿瘤发生的研究进展[J]. 实用肿瘤学杂志, 2019, 33(1): 73-77.
[10]	于芳, 赵培. TRAP1在食管癌发展中的作用及机制研究[J]. 实用肿瘤学杂志, 2018, 32(6): 515-519.
[11]	王亚龙, 吕章艳, 张帆, 冯小双, 魏锣沛, 李鑫, 温艳, 高禹舜, 薛奇, 高树庚, 谭锋维. 人乳头状瘤病毒感染与肺癌预后相关性的Meta分析[J]. 实用肿瘤学杂志, 2018, 32(6): 520-526.
[12]	唐淑丽, 何匡邦, 张纯慧, 程佳楠, 张艳桥. 胃癌组织中miR-320a和CYLD的表达及与临床病理特征及预后的关系[J]. 实用肿瘤学杂志, 2018, 32(6): 538-544.
[13]	阚钧, 周岱翰综述, 张恩欣审校. 肿瘤合并心血管疾病的研究进展[J]. 实用肿瘤学杂志, 2018, 32(6): 558-561.
[14]	顾琦晟综述, 李继坤审校. 锰超氧化物歧化酶在肿瘤发生发展过程中的研究进展[J]. 实用肿瘤学杂志, 2018, 32(6): 562-566.
[15]	刘娟综述, 张澍田审校. 细胞周期蛋白依赖性激酶抑制因子3在肿瘤中的研究进展[J]. 实用肿瘤学杂志, 2018, 32(6): 575-578.